Gland Pharma jumps on receiving approval from USFDA for Acetaminophen Injection
Gland Pharma rallied 4.06% to Rs 1,597.35 after the company received approval from the United States Food and Drug Administration (USFDA) for Acetaminophen Injection, 10 mg/mL (500 mg/50 mL and mg/100 ...
Pharmaceutical Technology on MSN17h
Organon acquires Actemra biosimilar’s US rights from Biogen
Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.
Managed Healthcare Executive1d
Organon Expands Biosimilar Portfolio With Tofidence Acquisition
Originally approved by the FDA in September 2023, Biogen's Tofidence became the first tocilizumab biosimilar available in the ...
80 years after World War II, Okinawa’s battle sites are still giving up bones and bombs
An estimated 240,000 people were killed or went missing in the Battle of Okinawa during World War II. Eighty years later, the ...
Organon acquires rights for Tofidence from Biogen
Organon (OGN) announced that it has acquired from Biogen (BIIB) regulatory and commercial rights in the U.S. for Tofidence, a biosimilar to ...
Nexus Pharmaceuticals Launches Fluorescein 2 mL
Nexus Pharmaceuticals, LLC is expanding their Fluorescein dosage options to include Fluorescein Injection, USP 25% in a 2 mL ...